Vertex Pharma (VRTX) Tops Q4 EPS by 24c, Revenues Beat; Offers FY19 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 537.03 +6.27 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $530.76 | 52 Week High | $134.71 | |||
| Open | $535.63 | 52 Week Low | $73.31 | |||
| Day High | $540.69 | P/E | N/A | |||
| Day Low | $534.00 | EPS | $-1.98 | |||
| Volume | 69,246 | |||||
